Sunday	(May 17, 1992) Interactive Discussions
	Session I-‘Troubleshooting Cell Culture Problems’
	Linda Minnich, Charleston Area Medical Center, Charleston WV
	Thomas Smith, Mayo Clinic, Rochester MN
	Ella Swierkosz, St. Louis University, St. Louis MO
	Session II-‘Reporting and Interpretation of Virology Laboratory Findings’
	Joseph L. Waner, Oklahoma Children’s Memorial Hospital, Oklahoma City OK
	James Luby, University of Texas Health Sciences at Dallas, Dallas TX
	Marilyn Menegus, University of Rochester School of Medicine and Dentistry, Rochester NY
Day 1	Monday (May 18, 1992) Session I-Clinical Aspects of Viral Diseases
	‘Cytomegalovirus Infections: Problems and Solutions’
	Raleigh Bowden, Fred Hutchinson Cancer Center, Seattle WA
	‘Human Herpesvirus 6: Disease and Diagnosis’, Steven F. Josephs, Baxter Health Care Corporation, Round Lake IL
	‘Prions, Amyloid Plaque and Central Nervous System Diseases’
	David Westaway, University of California at San Francisco, San Francisco CA
	‘Immunopathogenesis of AIDS: A Skewed View’
	Kenneth Rosenthal, McMaster University, Hamilton, Ontario, Canada
	‘Human Immunodeficiency Virus and Health Care Professionals: Medico-Legal Consideration’
	Joline Miceli-Mullen, University of South Florida College of Medicine, Tampa FL
Day 2	Tuesday (May 19, 1992) Session II-Diagnosis of Viral Infections
	‘Hepatitis C Virus; Diagnosis for Acute and Chronic Infections’
	Miriam Alter, Centers for Disease Control, Atlanta GA
	‘Transport Media Formulation and the Preservation of Clinical Specimens’
	James Brinker, University of Massachusetts Medical Center, Worcester MA
	‘Utility and Effectiveness of Direct Detection Methods in Viral Diagnosis’
	Lawrence Drew, Mt. Zion Hospital, San Francisco CA
	‘Applications of Flow Cytometry to Viral Diagnosis’
	James McSharry, Albany Medical College, Albany NY
	Panel Discussion: General Topics in Virology
Day 3	Wednesday (May 20, 1992) Session III-Prevention of and Therapy of Viral Infections
	‘Cytokine and Biological Response Modifier Therapy for Viral Infections’
	Robert T. Schooley, University of Colorado Health Sciences Center, Denver, CO
	‘Applications of a Chimeric Vaccine for Respiratory Syncytial Virus’
	Michael Wathen, The Upjohn Company, Kalamazoo MI
	‘Effectiveness of High Affinity Monoclonal Antibodies for Prophylaxis Against Viral Diseases’, Abner Louis Notkins, National Institutes of Health, Bethesda, MD
	‘Testing and Development of Anti-HIV Drugs’
	Erik De Clercq, Catholic University of Leaveu, Belgium
	‘Newer Applications for Acyclovir Therapy’
	Gray Davis, Burroughs Wellcome Company, Research Triangle Park NC